KRNY
Kearny Financial Corp.
KRNY offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MS
Morgan Stanley
MS has a slight edge over KRNY overall, supported by stronger modeled upside and stronger fundamentals.
KRNY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
KRNY's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like KRNY.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
KRNY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $9.15 | — |
| Cheap | 12x | $6.89 | -25% |
| Fair | 15x | $8.97 | -1.9% |
| Current | 16x | $9.15 | — |
| Expensive | 20x | $11.37 | +24% |
Historical ranges are pointers, not guarantees.
KRNY has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
KRNY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for KRNY, with profitability improving.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
KRNY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | +41% |
| Q3 2026 | $0.58 | +23% |
| Q2 2026 | $0.57 | +36% |
| Q1 2026 | $0.57 | +$1.71 |
| Q4 2025 | $0.52 | +$1.65 |
| Q3 2025 | $0.47 | +$1.92 |
| Q2 2025 | $0.42 | +$1.81 |
| Q1 2025 | -$1.14 | -556% |
| Q4 2024 | -$1.13 | -490% |
KRNY's earnings per share have fallen from their peak: $0.58 over the past year, against $1.01 in early 2022.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over KRNY on earnings, with more consistent year-over-year improvement.
KRNY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $45.3M | +4% |
| Q2 2026 | $45.7M | +12% |
| Q1 2026 | $45.3M | +17% |
| Q4 2025 | $43.5M | +16% |
| Q3 2025 | $43.6M | +17% |
| Q2 2025 | $40.8M | +4.5% |
| Q1 2025 | $38.6M | +0.2% |
| Q4 2024 | $37.5M | +89% |
KRNY's revenue has grown year over year for eight quarters in a row: $45M last quarter, up 4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 28% | +0.5 points |
| Q2 2026 | 24% | +4.1 points |
| Q1 2026 | 28% | +7.6 points |
| Q4 2025 | 27% | +6.2 points |
| Q3 2025 | 27% | +8.1 points |
| Q2 2025 | 20% | +253 points |
| Q1 2025 | 20% | -3.3 points |
| Q4 2024 | 21% | +82 points |
KRNY's operating margin was 28% last quarter, about level with the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over KRNY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over KRNY on profitability, with a higher operating margin.
KRNY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.3M | +520% |
| Q1 2026 | $7.9M | -53% |
| Q4 2025 | $14.3M | +$17M |
| Q3 2025 | $1.5M | -41% |
| Q1 2025 | $16.8M | -4.4% |
| Q4 2024 | -$2.7M | -139% |
| Q3 2024 | $2.5M | -79% |
| Q1 2024 | $17.6M | -17% |
KRNY has the stronger cash trend. Its trailing FCF is down 37% versus its history, compared with MS at down 492%.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
KRNY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +343K shares |
| 1 year | +1% | +612K shares |
| 3 years | +0.8% | +502K shares |
| 5 years | -15% | -11M shares |
| Available history | -23% | -19.3M shares |
KRNY has 64M diluted shares, up 1% from a year ago.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over KRNY on shareholder dilution, with a more favorable share count trend.
KRNY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 14.7x | High |
| Q3 2025 | 21.6x | High |
| Q2 2025 | 26.2x | High |
| Q1 2024 | 44.6x | High |
| Q4 2023 | 85.3x | High |
| Q3 2023 | 60.8x | High |
| Q2 2023 | 46.3x | High |
| Q1 2023 | 43.6x | High |
KRNY's net debt is about 15 years of its operating earnings (EBITDA), down from more than 20 years a year ago. Net leverage isn't a meaningful measure for financial services companies like KRNY.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
KRNY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.2 | Neutral |
| Stochastic | 19.3 | Oversold |
KRNY's weekly RSI is 52 (neutral) and its Stochastic is 19 (oversold).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
KRNY PE vs Financial Services Sector
| Metric | KRNY | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 21% above |
| PE % | 55 | 63 | 8 pts below |
KRNY is trading at 16x earnings, a 21% premium to the Financial Services sector's median of 13x.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over KRNY on valuation relative to its sector.
KRNY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.16 | 0.1% below |
| 20 week MA | $9.43 | 3% below |
| 50 week MA | $8.52 | 7.4% above |
| 100 week MA | $7.51 | 22% above |
| 200 week MA | $7.43 | 23% above |
KRNY has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 23% above its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
KRNY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.8 | $10.6 | -23% |
| 2021 | $10.6 | $13.1 | +24% |
| 2022 | $13.1 | $10.3 | -21% |
| 2023 | $10.3 | $8.97 | -13% |
| 2024 | $8.97 | $7.07 | -21% |
| 2025 | $7.07 | $7.58 | +7.2% |
| 2026 YTD | $7.58 | $9.15 | +21% |
KRNY has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.